NCT01513122View on ClinicalTrials.gov

Bone and Body Comp: A Sub Study of the SECOND-LINE Study

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

August 31, 2013

Conditions
HIV
Interventions
DRUG

Lopinavir / ritonavir

LPV/r 200mg/50mg 4 tabs once daily or 2 tabs twice daily

DRUG

2-3N(t)RTI

DRUG

raltegravir

raltegravir 400mg 1 tablet twice daily.

Trial Locations (7)

7925

Desmond Tutu HIV Foundation, Cape Town

10330

HIV-NAT Program on AIDS - Thai Red Cross, Bangkok

50603

University of Malaya Medical Centre, Kuala Lumpur

600113

YRGCare Medical Centre, Chennai

Unknown

CEADI, Buenos Aires

JOSHA Research, Bloemfontein

Chris Hani Baragwanath Hospital, Soweto

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
lead

Kirby Institute

OTHER_GOV